Navigation Links
Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
Date:8/14/2009

ale quantities over the second quarter 2008. Retail revenues accounting for 20% of total revenues decreased 24% due to weak consumer demand for non-essential drugs.

Gross margins for the second quarter of 2009 increased to 57.9% as compared to 50.0% in the second quarter of 2008. Dr. Zhongyi Liu, Chairman and CEO of Lotus commented, "We are very pleased with our growth in sales quantities and gross margins of this quarter. Our pricing policy for 2009 has been adjusted accordingly due to the expected inflation contraction on the wholesale level nationally. We have been able to reduce the cost of sales mainly because Active Pharmaceutical Ingredient ("API") and essential medicine prices have dropped since the onset of economic slowdown."

Total operating expenses for the second quarter 2009 were $2.6 million, a 63% decrease from the second quarter of 2008. The decrease resulted from the decrease of selling expenses in relation to our drugs that have established certain market shares, which was due to the profit margins we have given away to our agents who in turn are incentivized to sell our established drugs at competitive prices.

Dr. Liu commented, "We are very pleased to obtain the approval from the Beijing Land Planning Bureau for permitting us to build a new office building on our current production base which was previously industrial-use-only land in Beijing. This means that we can finally bring all of our operational units such as administration, sales, R&D and production into a single office building. This is another important step we made towards improving our operational efficiency."

Net income for the second quarter of 2009 was $4.8 million, or $0.10 per diluted share, compared to $2.2 million, or $0.05 per diluted share, in the second quarter of 2008.

The Company's cash position at the end of the second quarter was $1.8 million, compared to $1.3 million at the
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
2. Lotus Scarless Hair Transplantation (International) Medical Chain Institute Opens New Center on Beijings Prestigious ChangAn Avenue
3. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
4. NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
5. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
6. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
7. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
8. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
10. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014 Proove Biosciences , the ... presenting research on the association between specific genes and ... Psychiatric and Mental Health Congress’ 27th Annual Scientific ... on the theme of ‘Embracing Change.’ Mental health, and ... landscape. From the challenges presented by the Affordable Care ...
(Date:9/23/2014)... San Jose, California (PRWEB) September 23, 2014 ... – Agricultural biotechnology is gaining steady popularity the ... sophisticated plant breeding techniques. Growth in the marketplace ... Genetically Modified (GM) crops in developing countries. Several ... 30% of under-nourished population, have already implemented genetically ...
(Date:9/23/2014)... This is a professional and ... Isopropanol (IPA) industry. The report provides a basic ... industry chain structure. Global market analysis and Chinese ... on history, developments, trends and competitive landscape of ... Chinese situation is also offered. , The report ...
(Date:9/23/2014)... Marktech Optoelectronics has introduced the MTE280xxx series, its ... 280 nm wavelength range. This series joins Marktech’s current ... to 405nm. These new devices are suitable for applications ... Mark Campito, Marktech’s CEO states that “what makes this ... that we offer it in one of the largest ...
Breaking Biology Technology:Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3Marktech Introduces its New Line of Deep UV Emitters 2
... Split Effective at Close of Business Today ... - VGNI Stock Symbol to Change to VRGE, PLANTATION, ... majority-owned subsidiary,of Viragen, Inc. (OTC Bulletin Board: VRAI), today announced that ... outstanding common stock,will become effective at the close of business today, ...
... 4, Dow AgroSciences LLC, a wholly owned subsidiary,of ... and Exelixis Plant Sciences, a,wholly owned subsidiary of ... the companies have signed a major research collaboration ... Dow AgroSciences,affiliate Agrigenetics Inc. The agreement is focused ...
... forum for the global pharma/biotech industries, Pharmaceutical Manufacturing and Biotechnology Middle ... ... DUBAI, United Arab Emirates, Sept. 4 The Middle East,market for pharmaceutical ... growth in double digits. The market,drivers are: -- Dubai is the ...
Cached Biology Technology:Viragen International to Reverse Split Its Common Stock 2Viragen International to Reverse Split Its Common Stock 3Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 2Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 3
(Date:9/23/2014)... National Institutes of Health will award funds to support ... Screening program to improve ways of predicting drug safety ... refine existing 3-D human tissue chips and combine them ... functions of the human body. Led by the National ... support 11 institutions at $17 million in 2014 with ...
(Date:9/23/2014)... announced today that the Company has secured $21 million ... be used to expand the Company,s cancer immunotherapy pipeline ... investor Yuan Capital led the round, with participation from ... Ventures, Suma Venture and Harbinger Venture Capital. , ... fully-human antibodies engineered to mimic the functions of a ...
(Date:9/23/2014)... are the same ones that were used 50 years ago. ... disease, which causes nearly 25 million people in the United ... best to take a deep breath. , But finding ... what works for one person doesn,t necessarily work for another, ... candidates often fail to mimic human responses costing tremendous ...
Breaking Biology News(10 mins):NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4Airway muscle-on-a-chip mimics asthma 2Airway muscle-on-a-chip mimics asthma 3
... a great health threat, especially since routine smallpox ... treatment currently exists. In the February 1 issue ... and colleagues from Harvard Medical School propose a ... of signaling mediated by the smallpox growth factor ...
... research on prions, the infectious proteins behind "mad cow" disease ... prions in one species to infect other species depends on ... prion. Two studies on the topic appear in the 8 ... suggests that prions from one species rarely infect other species, ...
... tweaked to absorb more contaminants, researchers found that the ... results raised hopes that the plants might become a ... new research findings, published Feb. 1 in the journal ... of the Indian mustard plant, Brassica juncea, absorbed two ...
Cached Biology News:Fibril Shape Is The Basis Of Prion Strains And Cross-species Prion Infection 2Fibril Shape Is The Basis Of Prion Strains And Cross-species Prion Infection 3Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 2Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 3Transgenic plants remove more selenium from polluted soil than wild plants, new tests show 4
Recombinant Rat Leptin, Ultra Pure...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Biology Products: